Sergio A. Giralt, MD, FACP, is Chief Attending Physician of the Adult Bone Marrow Transplant Service in the Department of Medicine at Memorial Sloan Kettering Cancer Center and Professor of Medicine at Weill Cornell Medical College. He previously was employed as a faculty member at the University of Texas MD Anderson Cancer Center.
Dr. Giralt received his medical degree from the Universidad Central de Venezuela in Carcas, Venezuela. He later completed a residency at Good Samaritan Hospital and a fellowship at The University of Texas MD Anderson Cancer Center. He is board certified in internal medicine with subspecialties in medical oncology and hematology.
Dr. Giralt’s clinical and research activities include stem cell transplantation for patients with blood disorders and improving treatments for older patients who have acute and chronic leukemia. He was one of the pioneers of reduced intensity conditioning regimens which has allowed access to hematopoietic cell transplantation to thousands of older patients with blood cancers. He has published and presented extensively on these topics in prestigious meetings and journals. Additionally, Dr. Giralt has served as the principle investigator for a number of clinical trials that examine new treatment approaches for multiple myeloma and other blood cancers that aim to reduce symptom burden and improve treatment tolerability.
Dr. Giralt is an active member of the American Medical Association, the American College of Physicians, the American Society of Hematology, the American Society of Clinical Oncology, the North American Society of Blood and Bone Marrow Transplantation, the International Society of Hematotherapy and Graft Engineering, the International Society of Haematology, and the Gerontological Society of America. He previously served as Chairperson on the Executive Board of the Center for International Blood and Marrow Transplant Research and on the Steering Committee of the Blood and Marrow Transplant Clinical Trials Network and is the current past President of the American Society for Blood and Marrow Transplant.